Stamaril Caution For Usage

Incompatibilities: In the absence of compatibility studies, this vaccine must not be mixed with other medicinal products.
Special precautions for disposal: STAMARIL, powder and solvent for suspension for injection in prefilled syringe, Yellow fever vaccine (Live): For syringe without attached needle only: after removing the syringe tip cap, a needle should be firmly placed on the tip of the syringe and secured by rotating a quarter of a turn (90°).
The vaccine is reconstituted by adding the solvent provided in the pre-filled syringe to the vial of powder. The vial is shaken and, after complete dissolution, the suspension obtained is withdrawn into the same syringe for injection.
Before administration, the reconstituted vaccine should be vigorously shaken.
Use immediately after reconstitution.
After reconstitution the suspension is beige to pink beige, more or less opalescent.
Contact with disinfectants is to be avoided since they may inactivate the virus.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
STAMARIL, powder and solvent for suspension for injection in multidose container, Yellow fever vaccine (Live): The vaccine is reconstituted as follows: Inject a small quantity of 9 mg/mL (0.9%) sodium chloride solution for injection into the vial of powder.
Shake the vial until the powder turns into a homogeneous suspension.
Add the remaining sodium chloride solution for injection into the vial.
Before administration, the reconstituted vaccine should be vigorously shaken.
For each vaccination, 0.5 mL is withdrawn.
The reconstitution and withdrawal of vaccine should be performed under aseptic conditions.
After reconstitution, the suspension is beige to pink beige, more or less opalescent.
Contact with disinfectants is to be avoided since they may inactivate the virus.
Any unused product or waste material should be disposed of, preferably by heat inactivation or incineration, in accordance with local requirements.